BASF increases cash offer for Pronova BioPharma
date:Jan 17, 2013
egate have accepted the offer for a number of shares representing more than 90% of the total share capital of Pronova.

As of Jan. 14, BASF has received acceptances under the voluntary offer for a number of shares representing approximately 70% of the issued shares and votes in Pronova. BASF has obtained irrevocable pre-acceptance commitments for approximately 60% of Pronovas share capital; including the 50% stake held by majority shareholders Herkules Private Equity Fund, an approximately 9.1%
4/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/27 16:30